Accuray (ARAY) Misses Q2 EPS by 5c, Reaffirms FY Guidance

Accuray (NASDAQ: ARAY) reported Q2 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $98.2 million versus the consensus estimate of $98.87 million.

Accuray reaffirmed its financial guidance for fiscal year 2015 as follows: total revenue of $390.0 million to $410.0 million and adjusted EBITDA of $18.0 million to $27.0 million

For earnings history and earnings-related data on Accuray (ARAY) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30